Previous 10 | Next 10 |
DALLAS and FORT WORTH, Texas, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally...
Neos Therapeutics (NASDAQ: NEOS ) has entered into a confidential settlement and licensing agreement with Teva Pharmaceuticals (NYSE: TEVA ) to resolve all ongoing litigation involving Neos' patents protecting its Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tab...
DALLAS and FORT WORTH, Texas, Dec. 26, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally...
– Strategic assessment leads to new salesforce structure and is expected to accelerate path to profitability – – Company to host conference call today at 8:30am ET – DALLAS and FORT WORTH, Texas, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Neos Therapeut...
DALLAS and FORT WORTH, Texas, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a fully-integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative modified-release products using its proprietary microparticle, drug delivery t...
OncoSec Medical (NASDAQ: ONCS ) -58% on mid-stage TAVO data . More news on: OncoSec Medical Incorporated, frontdoor, inc., AAC Holdings, Inc., Stocks on the move, , Top stock market news, Read more ...
More news on: e.l.f. Beauty, Commercial Vehicle Group, Inc., Fabrinet, Stocks on the move, , News on ETFs, Read more ...
The company is offering an undisclosed amount of shares, with underwriter greenshoe for another 15% of the number of shares sold. More news on: Neos Therapeutics, Healthcare stocks news, Stocks on the move, Read more ...
DALLAS and FORT WORTH, Texas, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a fully-integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative modified-release products using its proprietary microparticle, drug delivery t...
DALLAS and FORT WORTH, Texas, , Nov. 02, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS) today announced that it will report third quarter 2018 financial results prior to the opening of U.S. financial markets on Friday, November 9, 2018. Neos management will host a conferenc...
News, Short Squeeze, Breakout and More Instantly...
Neos Therapeutics Inc. Company Name:
NEOS Stock Symbol:
NASDAQ Market:
Neos Therapeutics Inc. Website:
Penny Stock News Triggers Momentum In These Cheap Stocks When it comes to penny stocks, there are plenty of different catalysts to consider. You could look for general market trends or sector/industry-based themes. However, these are more along the line of technical catalysts. On the ot...
– The Neos Therapeutics Board of Directors recommend stockholders vote “FOR” the transaction in advance of the virtual special meeting scheduled for March 18, 2021 at 10:00 a.m. Eastern Time – – Stockholders are encouraged to vote, no matt...
– The Neos Therapeutics Board of Directors recommend stockholders vote “FOR” the transaction in advance of the virtual special meeting scheduled for March 18, 2021 at 10:00 a.m. Eastern Time – – Stockholders are encouraged to vote, no matt...